Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer
NCT04481932
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
104
Enrollment
OTHER
Sponsor class
Conditions
HER2-positive Breast Cancer
Interventions
DRUG:
Trastuzumab combined with Pyrotinib and chemotherapy
Sponsor
Peking University